SG10201912682XA - Albumin-sugar chain complex - Google Patents
Albumin-sugar chain complexInfo
- Publication number
- SG10201912682XA SG10201912682XA SG10201912682XA SG10201912682XA SG10201912682XA SG 10201912682X A SG10201912682X A SG 10201912682XA SG 10201912682X A SG10201912682X A SG 10201912682XA SG 10201912682X A SG10201912682X A SG 10201912682XA SG 10201912682X A SG10201912682X A SG 10201912682XA
- Authority
- SG
- Singapore
- Prior art keywords
- albumin
- sugar chain
- chain complex
- complex
- sugar
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/76—Albumins
- C07K14/765—Serum albumin, e.g. HSA
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/54—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic compound
- A61K47/549—Sugars, nucleosides, nucleotides or nucleic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid
- A61K47/64—Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
- A61K47/643—Albumins, e.g. HSA, BSA, ovalbumin or a Keyhole Limpet Hemocyanin [KHL]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0056—Peptides, proteins, polyamino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Toxicology (AREA)
- Biophysics (AREA)
- Gastroenterology & Hepatology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Inorganic Chemistry (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2015132002 | 2015-06-30 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG10201912682XA true SG10201912682XA (en) | 2020-03-30 |
Family
ID=57608323
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201710829WA SG11201710829WA (en) | 2015-06-30 | 2016-06-30 | Albumin-sugar chain complex |
SG10201912682XA SG10201912682XA (en) | 2015-06-30 | 2016-06-30 | Albumin-sugar chain complex |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201710829WA SG11201710829WA (en) | 2015-06-30 | 2016-06-30 | Albumin-sugar chain complex |
Country Status (11)
Country | Link |
---|---|
US (1) | US10683341B2 (en) |
EP (1) | EP3318575B1 (en) |
JP (1) | JP6956959B2 (en) |
KR (1) | KR102611306B1 (en) |
CN (1) | CN107750252B (en) |
AU (1) | AU2016286027B2 (en) |
CA (1) | CA2991013C (en) |
DK (1) | DK3318575T3 (en) |
SG (2) | SG11201710829WA (en) |
TW (1) | TWI757238B (en) |
WO (1) | WO2017002918A1 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW202110482A (en) * | 2019-05-24 | 2021-03-16 | 日商糖鎖工學研究所股份有限公司 | Novel artificial protein catalyst |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7943763B2 (en) * | 2002-07-05 | 2011-05-17 | Otsuka Chemical Holdings Co., Ltd. | Process for preparing glycopeptides having asparagine-linked oligosaccharides, and the glycopeptides |
TWI466897B (en) * | 2005-07-19 | 2015-01-01 | Glytech Inc | Method of dotecting cancer cells, method of structure analysis for sugar chain, and sugar chain derivatives |
JP4449915B2 (en) | 2006-02-08 | 2010-04-14 | ソニー株式会社 | Encoding apparatus, encoding method and program, and recording medium |
JP4983148B2 (en) | 2006-08-18 | 2012-07-25 | ニプロ株式会社 | Glycan-containing albumin, method for producing the same, and use thereof |
US8298513B2 (en) | 2007-02-05 | 2012-10-30 | Osaka University | Hexatriene-β-carbonyl compound |
US7943570B2 (en) | 2007-10-16 | 2011-05-17 | Nipro Corporation | Sugar chain-containing albumin, production method thereof and use thereof |
JP5975577B2 (en) * | 2011-03-04 | 2016-08-23 | 株式会社糖鎖工学研究所 | Method for producing sialic acid-containing sugar chain |
JP6327547B2 (en) | 2013-08-02 | 2018-05-23 | 国立研究開発法人理化学研究所 | New compounds and their use |
-
2016
- 2016-06-30 SG SG11201710829WA patent/SG11201710829WA/en unknown
- 2016-06-30 JP JP2017526430A patent/JP6956959B2/en active Active
- 2016-06-30 TW TW105120821A patent/TWI757238B/en active
- 2016-06-30 CN CN201680038209.4A patent/CN107750252B/en active Active
- 2016-06-30 CA CA2991013A patent/CA2991013C/en active Active
- 2016-06-30 SG SG10201912682XA patent/SG10201912682XA/en unknown
- 2016-06-30 EP EP16818026.3A patent/EP3318575B1/en active Active
- 2016-06-30 US US15/740,511 patent/US10683341B2/en active Active
- 2016-06-30 KR KR1020177037467A patent/KR102611306B1/en active IP Right Grant
- 2016-06-30 AU AU2016286027A patent/AU2016286027B2/en active Active
- 2016-06-30 WO PCT/JP2016/069438 patent/WO2017002918A1/en active Application Filing
- 2016-06-30 DK DK16818026.3T patent/DK3318575T3/en active
Also Published As
Publication number | Publication date |
---|---|
US20180186859A1 (en) | 2018-07-05 |
AU2016286027A1 (en) | 2018-01-25 |
KR20180021727A (en) | 2018-03-05 |
JP6956959B2 (en) | 2021-11-02 |
DK3318575T3 (en) | 2021-04-12 |
EP3318575A1 (en) | 2018-05-09 |
US10683341B2 (en) | 2020-06-16 |
CA2991013A1 (en) | 2017-01-05 |
KR102611306B1 (en) | 2023-12-06 |
EP3318575A4 (en) | 2019-03-13 |
EP3318575B1 (en) | 2021-01-06 |
TW201705976A (en) | 2017-02-16 |
TWI757238B (en) | 2022-03-11 |
CN107750252A (en) | 2018-03-02 |
WO2017002918A1 (en) | 2017-01-05 |
SG11201710829WA (en) | 2018-02-27 |
JPWO2017002918A1 (en) | 2018-04-26 |
AU2016286027B2 (en) | 2020-02-27 |
CA2991013C (en) | 2023-09-26 |
CN107750252B (en) | 2021-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK3389557T3 (en) | Transseptalt leveringssystem | |
DK3320033T3 (en) | Polyethylenterephthalat-depolymerisering | |
DK3256579T3 (en) | Cysteinprotease | |
DK3256580T3 (en) | Cysteinprotease | |
DK3298030T3 (en) | Anti-cancerfusionspolypeptid | |
DK3250592T3 (en) | Anti-transthyretin-antistoffer | |
GB201512299D0 (en) | Links | |
DK3284069T3 (en) | Pos-terminal | |
DK3390996T3 (en) | Trykbart tids-temperaturindikatorsystem | |
DK3380145T3 (en) | Injektionsapparat | |
DK3336185T3 (en) | Antistof | |
DK3272750T3 (en) | Morphinan-derivat | |
DK3324768T3 (en) | Tørdragt | |
PT3348859T (en) | Chain | |
AU361999S (en) | Ballustrade | |
DK3133099T3 (en) | Polymermodificeret polyoldispersion | |
PL2960545T3 (en) | Rigid-spined push chain | |
DK3282866T3 (en) | Proteinfibre | |
DK3250312T3 (en) | Urea-metalnitrat-scr-system | |
DK3294653T3 (en) | Justerbar inline-port | |
PL2957187T3 (en) | Ornamental chain | |
SG11201710829WA (en) | Albumin-sugar chain complex | |
HK1217529A1 (en) | Chain | |
DK3242882T3 (en) | Cgrp-antagonistpeptider | |
GB201522490D0 (en) | Conveyor chain |